» Articles » PMID: 39179934

Clonal Succession After Prolonged Antiretroviral Therapy Rejuvenates CD8 T Cell Responses Against HIV-1

Abstract

Human immunodeficiency virus 1 (HIV-1) infection is characterized by a dynamic and persistent state of viral replication that overwhelms the host immune system in the absence of antiretroviral therapy (ART). The impact of prolonged treatment on the antiviral efficacy of HIV-1-specific CD8 T cells has nonetheless remained unknown. Here, we used single-cell technologies to address this issue in a cohort of aging individuals infected early during the pandemic and subsequently treated with continuous ART. Our data showed that long-term ART was associated with a process of clonal succession, which effectively rejuvenated HIV-1-specific CD8 T cell populations in the face of immune senescence. Tracking individual transcriptomes further revealed that initially dominant CD8 T cell clonotypes displayed signatures of exhaustion and terminal differentiation, whereas newly dominant CD8 T cell clonotypes displayed signatures of early differentiation and stemness associated with natural control of viral replication. These findings reveal a degree of immune resilience that could inform adjunctive treatments for HIV-1.

Citing Articles

Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.

Bertrand L, Nelde A, Ramirez B, Hatin I, Arbes H, Francois P Nat Commun. 2025; 16(1):1707.

PMID: 39966340 PMC: 11836469. DOI: 10.1038/s41467-025-56773-2.


BACH2-driven tissue resident memory programs promote HIV-1 persistence.

Wei Y, Ma H, Wong M, Papasavvas E, Konnikova L, Tebas P bioRxiv. 2025; .

PMID: 39763845 PMC: 11702684. DOI: 10.1101/2024.12.16.628794.


Long-term antiretroviral therapy rejuvenates the HIV-specific CD8 T cell response.

Blankson J Nat Immunol. 2024; 25(9):1513-1514.

PMID: 39179933 DOI: 10.1038/s41590-024-01924-8.

References
1.
Finzi D, Hermankova M, Pierson T, Carruth L, Buck C, Chaisson R . Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997; 278(5341):1295-300. DOI: 10.1126/science.278.5341.1295. View

2.
Wong J, Hezareh M, Gunthard H, Havlir D, Ignacio C, Spina C . Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997; 278(5341):1291-5. DOI: 10.1126/science.278.5341.1291. View

3.
Hamer D . Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it. Curr HIV Res. 2004; 2(2):99-111. DOI: 10.2174/1570162043484915. View

4.
Appay V, Douek D, Price D . CD8+ T cell efficacy in vaccination and disease. Nat Med. 2008; 14(6):623-8. DOI: 10.1038/nm.f.1774. View

5.
Saez-Cirion A, Pancino G, Sinet M, Venet A, Lambotte O . HIV controllers: how do they tame the virus?. Trends Immunol. 2007; 28(12):532-40. DOI: 10.1016/j.it.2007.09.002. View